VA launches massive study of COVID-19 drugs in 400,000 veterans
NCT ID NCT06160128
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 26 times
Summary
This study looks at how COVID-19 treatments like Paxlovid and remdesivir are used in the VA healthcare system and how well they work. Researchers will study up to 400,000 veterans to compare treatments, track hospitalizations and deaths, and also examine flu and RSV vaccines and therapies. The goal is to learn which treatments are most effective for different groups over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Portland Health Care System, Portland, OR
RECRUITINGPortland, Oregon, 97207-2964, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.